• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

2024 Serious Hazards of Transfusions (SHOT) Report in the U.K.

August 6, 2025

The Royal College of Pathologists in the United Kingdom recently published their annual report for 2024 on the Serious Hazards of Transfusions (SHOT). Approximately 2.2 million blood components were issued in the U.K. in 2024, and the risk of serious harm from a transfusion was 1 in 11,500 components issued. The total number of reports analyzed in 2024 was 3,998—similar to the total in 2023. No cases of transfusion-transmitted infections were reported in 2024. Alarmingly, the number of deaths from transfusions, however, increased significantly from 38 deaths in 2023 to 59 deaths in 2024, mainly due to pulmonary complications such as TACO (n=31) and transfusion delays (n=18). From 2023 to 2024, the total number of delayed transfusions increased by a third to 312 and the number of deaths doubled. Miscommunication was the most cited reason for delayed transfusions. Errors accounted for 83% of all reports (3322/3998), the majority of which were preventable. The Royal College of Pathologists stresses that the transfusion community needs to address transfusion errors and delays by ensuring teams are well-resourced with adequate staffing, training, and supervision. They have also made a baseline assessment tool and compliance check for transfusion safely standards to assist transfusion teams identify risks and monitor progress.

Reference:

Narayan, S. et al., 2025. The 2024 Annual SHOT Report, Manchester: Serious Hazards of Transfusion (SHOT) Steering Group.

Filed Under

  • Adverse Events (non-infectious)
  • News

Recommended

  • Restrictive or Liberal Transfusion Thresholds for Patients with Myocardial Infarctions

  • Efficacy of High-Dose G-CSF for Granulocytopenic Patients is Inconclusive

  • Daprodustat is Noninferior to Erythropoiesis-Stimulating Agents for Patients with Chronic Kidney Disease Undergoing Dialysis

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Ferritin Levels Needed to Assess Hemoglobin Recovery after Blood Donation

  • Transfusion of RBCs from Cord Blood May Protect Low-Weight Preterm Infants from Severe Retinopathy

  • AABB Guidelines Recommend Liberal RBC Transfusion for Patients with Acute Myocardial Infarction

  • Artificial Intelligence to Predict Immunogenicity of Amino Acid Substitutions of Blood Group Antigens

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley